Geert Walther Nygaard
Vorstandsvorsitzender bei IBL International GmbH
Profil
Geert Walther Nygaard is currently the Co-Managing Director at IBL International GmbH.
Previously, he was the Chief Executive Officer at Glycorex Transplantation AB from 2021 to 2022, and at Epigenomics AG from 2007 to 2010.
He also served as a Director at Abbott GmbH (Germany) in 2012.
Nygaard completed his undergraduate degree at the Technical University of Denmark.
Aktive Positionen von Geert Walther Nygaard
| Unternehmen | Position | Beginn |
|---|---|---|
IBL International GmbH
 IBL International GmbH Miscellaneous Commercial ServicesCommercial Services IBL International GmbH develops and produces products for the medical-diagnostics laboratories. The company provides research services in the fields of enzyme, radio and luminescence immunoassays. The firm provides products in the diagnostic fields of Endocrinology, Catecholamines, Neuroscience, Tumormarkers, Hypertension, Cytokines, Adhesion Molecules, Autoimmunity, Immunology and Infectious Diseases. IBL International was founded in 1983 and is headquartered in Hamburg, Germany. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Geert Walther Nygaard
| Unternehmen | Position | Ende |
|---|---|---|
| GLYCOREX TRANSPLANTATION AB | Vorstandsvorsitzender | 08.12.2022 |
| EPIGENOMICS AG | Präsident | 30.09.2012 |
Abbott GmbH (Germany)
 Abbott GmbH (Germany) Pharmaceuticals: MajorHealth Technology Abbott GmbH & Co. KG develops and manufactures health care products. It is engaged in the discovery, development, manufacture, and marketing of pharmaceutical, diagnostic, nutritional, and hospital products. It offers pharmaceutical and diagnostic products ranging from prevention and diagnosis to treatment and cure. The company is headquartered in Ludwigshafen, Germany. | Direktor/Vorstandsmitglied | - |
Ausbildung von Geert Walther Nygaard
| Technical University of Denmark | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| EPIGENOMICS AG | Health Technology |
| GLYCOREX TRANSPLANTATION AB | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Abbott GmbH (Germany)
Abbott GmbH (Germany) Pharmaceuticals: MajorHealth Technology Abbott GmbH & Co. KG develops and manufactures health care products. It is engaged in the discovery, development, manufacture, and marketing of pharmaceutical, diagnostic, nutritional, and hospital products. It offers pharmaceutical and diagnostic products ranging from prevention and diagnosis to treatment and cure. The company is headquartered in Ludwigshafen, Germany. | Health Technology |
IBL International GmbH
IBL International GmbH Miscellaneous Commercial ServicesCommercial Services IBL International GmbH develops and produces products for the medical-diagnostics laboratories. The company provides research services in the fields of enzyme, radio and luminescence immunoassays. The firm provides products in the diagnostic fields of Endocrinology, Catecholamines, Neuroscience, Tumormarkers, Hypertension, Cytokines, Adhesion Molecules, Autoimmunity, Immunology and Infectious Diseases. IBL International was founded in 1983 and is headquartered in Hamburg, Germany. | Commercial Services |
